Resilience nets another deal, this time with billionaire’s cancer research center
Resilience is having a fun week. Fresh off a $625 million Series D and the launch of a joint venture with MD Anderson, the biomanufacturer Resilience has inked another partnership with an influential cancer center.
Billionaire Napster founder Sean Parker’s Parker Institute for Cancer Immunotherapy (PICI) and Resilience on Wednesday cracked open a five-year strategic alliance to develop and manufacture cancer therapies generated from PICI’s network of immunotherapy research centers.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.